Treatment and Supportive Care for Ehlers-Danlos Syndrome
The treatment and supportive care for Ehlers-Danlos syndrome requires a multidisciplinary approach focused on subtype-specific interventions, with management of vascular complications being most critical for mortality reduction, while symptom management and physical therapy form the cornerstone of care for hypermobile EDS. 1, 2
Subtype-Specific Management
Vascular EDS (Type IV)
- Regular vascular surveillance using non-invasive imaging (Doppler ultrasound, CT, or MRI) is essential to monitor the aorta and peripheral arteries 1
- Baseline imaging from head to pelvis should be performed with annual surveillance for dilated or dissected segments 1, 2
- Celiprolol (a beta-blocker with vasodilatory properties) is recommended to reduce vascular morbidity, showing a three-fold decrease in arterial rupture 1, 3
- Invasive diagnostic procedures should be strictly avoided due to risk of fatal complications; non-invasive imaging is strongly preferred 1, 4
- Surgical repair carries increased risk due to tissue fragility and should only be performed at tertiary centers with expertise in connective tissue disorders 1, 3
- Pregnancy in vascular EDS carries significant risks due to potential uterine rupture and vessel rupture during delivery 1
Hypermobile EDS (Most Common Type)
- Treatment should focus on managing prominent GI symptoms and abnormal GI function test results 5, 1
- For patients with comorbid POTS and chronic upper GI symptoms, diagnostic testing of gastric motor functions should be considered 5, 1
- Special diets including gastroparesis diet and various elimination diets can be considered with appropriate nutritional counseling 5, 1
- POTS treatment includes increasing fluid and salt intake, exercise training, and compression garments 5, 1
- Pharmacological treatments for volume expansion, heart rate control, and vasoconstriction should be considered for patients who don't respond to conservative measures 1
Gastrointestinal Management
- Diagnostic evaluation of GI symptoms should follow a similar approach to the evaluation of disorders of gut-brain interaction in the general population 5
- Testing for celiac disease may be considered earlier in the diagnostic evaluation of patients with various GI symptoms 5
- Diagnostic testing for functional defecation disorders should be considered in patients with lower GI symptoms due to high prevalence of pelvic floor dysfunction 5
- When MCAS (Mast Cell Activation Syndrome) is suspected, treatment with histamine receptor antagonists and/or mast cell stabilizers is beneficial 5
- Avoid triggers such as certain foods, alcohol, strong smells, temperature changes, mechanical stimuli, emotional distress, or specific medications 5
Musculoskeletal Management
- Physical therapy focusing on joint stabilization and muscle strengthening is essential for managing joint hypermobility 6, 7
- Bracing and supportive devices may be necessary for unstable joints 6
- Opioids should be avoided for chronic pain management, especially in patients with gastrointestinal manifestations 1, 2
- Brain-gut behavioral therapies are recommended due to increased rates of anxiety and psychological distress 1, 2
Perioperative Considerations
- Anesthesia requires special considerations due to tissue fragility and potential complications 8
- For vascular EDS, careful hemodynamic monitoring is essential to avoid sudden blood pressure changes 8
- Joint hypermobility requires careful positioning during surgery to prevent dislocations 8
- Wound healing complications are common, requiring meticulous surgical technique 6, 8
Monitoring and Follow-up
- Regular follow-up with a multidisciplinary team is essential for all EDS subtypes 1, 2
- Genetic testing is recommended for definitive diagnosis, particularly for identification of causal variants in vascular EDS (COL3A1) 1, 9
- For vascular EDS patients with stable findings, imaging intervals can be extended after demonstrating stability 2
Common Pitfalls to Avoid
- Invasive diagnostic procedures in vascular EDS patients should be avoided due to risk of fatal complications 1, 4
- Opioid use for chronic pain management should be avoided, especially with gastrointestinal manifestations 1, 2
- Parenteral nutrition should be avoided in hEDS patients without true intestinal failure 2
- Diagnostic catheter angiography carries increased risks; non-invasive imaging should be used whenever possible 1